Article
Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors
1 Mar 2024
Abstract excerpt
SMADs are the canonical intracellular effector proteins of the TGF-β (transforming growth factor-β). SMADs translocate from plasma membrane receptors to the nucleus regulated by many SMAD-interacting proteins through phosphorylation and other post-translational modifications that govern their nucleocytoplasmic shuttling and subsequent transcriptional activity. The signaling pathway of TGF-β/SMAD exhibits both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
